MyEClinic
MyEClinic
Health Dictionary Find a Doctor

Atypical teratoid rhabdoid tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Atypical teratoid rhabdoid tumor comprises approximately 1 – 2% of all pediatric brain tumors; however, in patients less than 3 years of age, this tumor accounts for up to 20% of cases. The incidence of atypical teratoid rhabdoid tumor is approximately 0.3 per 100,000 individuals in the United States. Atypical teratoid rhabdoid tumor is a rare disease that tends to affect the children. The median age at diagnosis is approximately 24 – 30 months. Males are more commonly affected with atypical teratoid rhabdoid tumor than females. The male to female ratio is approximately 1.9 to 1.

Epidemiology and Demographics

Incidence

  • The incidence of atypical teratoid rhabdoid tumor is approximately 0.3 per 100,000 individuals in the United States.[1]

Prevalence

  • Atypical teratoid rhabdoid tumor comprises approximately 1 – 2% of all pediatric brain tumors; however, in patients less than 3 years of age, this tumor accounts for up to 20% of cases.[2]

Age

  • Atypical teratoid rhabdoid tumor is a rare disease that tends to affect the children.[3][4]
  • However, although rare, atypical teratoid rhabdoid tumor has also been reported in adult patients.[5]
  • The median age at diagnosis is approximately 24 – 30 months.[6]

Race

  • There is no racial predilection to atypical teratoid rhabdoid tumor.

Gender

  • Males are more commonly affected with atypical teratoid rhabdoid tumor than females. The male to female ratio is approximately 1.9 to 1.[2]

References

  1. ↑ Atypical teratoid rhabdoid tumor. Wikipedia 2015. https://en.wikipedia.org/wiki/Atypical_teratoid_rhabdoid_tumor. Accessed on December 10, 2015
  2. ↑ 2.0 2.1 Ginn, Kevin F.; Gajjar, Amar (2012). “Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions”. Frontiers in Oncology. 2. doi:10.3389/fonc.2012.00114. ISSN 2234-943X.
  3. ↑ Epidemiology of atypical teratoid rhabdoid tumor. Dr Bruno Di Muzio and Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/atypical-teratoidrhabdoid-tumour. Accessed on December 10, 2015
  4. ↑ Clinical presentation of atypical teratoid rhabdoid tumor. National Cancer Institute 2015. http://www.cancer.gov/types/brain/hp/child-cns-atrt-treatment-pdq#link/_113_toc. Accessed on December 16, 2015
  5. ↑ Udaka, Y. T.; Shayan, K.; Chuang, N. A.; Crawford, J. R. (2013). “Atypical Presentation of Atypical Teratoid Rhabdoid Tumor in a Child”. Case Reports in Oncological Medicine. 2013: 1–4. doi:10.1155/2013/815923. ISSN 2090-6706.
  6. ↑ Slavc, Irene; Chocholous, Monika; Leiss, Ulrike; Haberler, Christine; Peyrl, Andreas; Azizi, Amedeo A.; Dieckmann, Karin; Woehrer, Adelheid; Peters, Christina; Widhalm, Georg; Dorfer, Christian; Czech, Thomas (2014). “Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012”. Cancer Medicine. 3 (1): 91–100. doi:10.1002/cam4.161. ISSN 2045-7634.

Template:WH Template:WS

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH